Related Experiment Video
Updated: Apr 9, 2026
04:37
Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
1.4K
Prosthetic joint infections in the elderly.
G De Angelis1, N T Mutters2, L Minkley3
1Department of Microbiology, Catholic University, largo A. Gemelli 8, 00164, Rome, Italy.
Infection
|June 23, 2015
Summary
The global elderly population is growing, increasing the risk of prosthetic joint infections (PJIs) after total joint arthroplasty. Early action is crucial to reduce PJI complications and mortality in this demographic.
Area of Science:
- Geriatric Medicine
- Infectious Diseases
- Orthopedic Surgery
Background:
- Global population aging is projected to increase the incidence of age-related diseases like osteoarthritis.
- This demographic shift will lead to more elderly patients undergoing total joint arthroplasty, raising concerns about complications.
- Prosthetic joint infections (PJIs) are a significant threat, associated with high mortality, prolonged antibiotic use, immobility, and revision surgeries.
Purpose of the Study:
- To review the current understanding of prosthetic joint infections (PJIs) in the elderly.
- To summarize key epidemiological, microbiological, and therapeutic aspects relevant to this population.
Main Methods:
- Systematic literature review.
- Analysis of epidemiological data on PJIs in older adults.
- Compilation of microbiological profiles and treatment strategies for PJI in the elderly.
Main Results:
- The elderly population is at increased risk for prosthetic joint infections following arthroplasty.
- PJIs in the elderly present unique challenges due to comorbidities and altered immune responses.
- Effective management requires a multidisciplinary approach, addressing infection control, antimicrobial therapy, and surgical intervention.
Conclusions:
- Prosthetic joint infections pose a growing challenge due to the aging global population.
- A coordinated European strategy is needed to mitigate the rising morbidity and mortality associated with PJIs in the elderly.
- Proactive measures and standardized treatment protocols are essential to improve outcomes for elderly patients with PJIs.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
327
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
327
01:22Healthcare Associated Infections II: Preventive Measures
4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
6.7K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.7K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
323
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
323
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
338
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
338
01:15Drug Dosing: Geriatric Patients
358
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
358